Stoma Care Market Analysis

Stoma Care Market Analysis

Based on product, the stoma care market is segmented as ostomy bags and accessories. The ostomy bags segment was valued at around USD 2.7 billion in 2022. This significant market share is owing to several benefits offered by ostomy bags in stoma surgery. Ostomy bags effectively contain bodily waste, minimizing the risk of leakage and maintaining good hygiene. These bags have built-in filters that help neutralize odours, providing confidence and comfort in social situations. Ostomy bags help protect the skin around the stoma from contact with waste, reducing the risk of surgical site infections.
 

Moreover, ostomy bags are available in a variety of options including one-piece and two-piece systems. The two-piece systems allow for separate attachment of the pouch and barrier providing protection between the skin and adhesive materials, reducing the risk of skin irritation. As the IBD procedure continues to increase, the demand for specialized ostomy bags that facilitate these procedures also increases. These bags allow for enhanced quality of life for the patients by providing a convenient and discreet way to manage waste elimination without the need for constant proximity to a restroom.
 

Based on surgery, the stoma care market is segmented as colostomy, ileostomy, and urostomy. The colostomy surgery segment was valued at around USD 1.5 billion in 2022. This significant market share is attributable to the rising geriatric population and increases in the risk of colorectal cancer cases. According to Who data, in 2020, around 1.8 million people globally were diagnosed with colorectal cancer worldwide accounting for around 1.1 million colon cancer cases and 0.7 million rectal cancer cases. This rising prevalence of colorectal cancer and other chronic ailments increases the demand for colostomy bags.
 

Furthermore, the increasing geriatric population is more prone to colon cancer and other diseases, that is further accelerating the need for colostomy surgeries. According to Union for International Cancer Control 2023, people aged 65 years and above are 11 times more likely to develop colorectal cancer as compared to younger people. Cancer in elderly people and colostomy treatment procedures will continue to grow over the projected period and is expected to contribute to the segment growth.
 

Based on end-use, the stoma care market is segmented into hospitals and specialty clinics, ambulatory surgical centers (ASCs), and home care settings. The home care settings segment is projected to reach around USD 2.6 billion by 2032. This majority market share is owing to the soaring demand for home healthcare, enhanced comfort and flexibility thereby surging the patient preference for home care settings. Patients who have undergone stoma surgeries often require stoma care over a long duration of time. The majority of people choose to recover at home rather than in hospitals or clinics. Advancements in telemedicine and digital health technologies enable healthcare providers to remotely monitor and guide patients in stoma care management. Patients can receive real-time guidance and support from healthcare professionals without leaving their homes.
 

Home care allows for more personalized stoma care. Patients receive one-on-one attention and can actively participate in their care plan, leading to better outcomes. The increasing preference for home care settings for stoma care aligns with the broader trend of patient-centred care and can lead to improved patient outcomes, increased patient satisfaction, and more efficient healthcare delivery. Additionally, less cost associated with home care settings is estimated to boost demand, thereby propelling the segment revenue.
 

North America region held a substantial share in the global stoma care market and was valued at over USD 646 million in 2022. This high market share is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from IBD, an expanding elderly population, among others. North America has a well-established healthcare infrastructure, a strong emphasis on technological advancements, and a high burden of chronic diseases, that drives the demand for stoma care. Increasing prevalence of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis in the region is anticipated to drive the product adoption rate.
 

The aging population in North America is contributing to an increased demand for healthcare services, including stoma care. Older adults are more susceptible to conditions that may require ostomy surgery, and they require ongoing support and care to manage their stomas. North America has a well-developed healthcare infrastructure with access to advanced medical technologies and treatments. This includes a wide range of stoma care products and services that are readily available to patients, contributing to the demand for these products.